Fresenius Medical Care Corporation (FMS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Fresenius Medical Care Corporation

NYSE | FMS

26.82

USD

$0.00

(

0.00%

)

At Close (As of Oct 10, 2025)

$15.78B

Market Cap

20.63

P/E Ratio

1.3

EPS

$29.71

52 Week High

$18.43

52 Week Low

HEALTHCARE

Sector

FMS Chart

Recent Chart

Price Action

FMS Technicals

Tags:

FMS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (EUR)
Gross Profit	$4.8B
Total Revenue	$19B
Cost Of Revenue	$15B
Costof Goods And Services Sold	$15B
Operating Income	$1.4B
Selling General And Administrative	$2.4B
Research And Development	$183M
Operating Expenses	$3.4B
Investment Income Net	-
Net Interest Income	-$335M
Interest Income	$72M
Interest Expense	$407M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$1.7B
Income Before Tax	$1.1B
Income Tax Expense	$316M
Interest And Debt Expense	-
Net Income From Continuing Operations	$741M
Comprehensive Income Net Of Tax	-
Ebit	$1.5B
Ebitda	$3.2B
Net Income	$538M

Revenue & Profitability

Earnings Performance

FMS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (EUR)
Total Assets	$34B
Total Current Assets	$7.9B
Cash And Cash Equivalents At Carrying Value	$1.2B
Cash And Short Term Investments	$1.2B
Inventory	$2.1B
Current Net Receivables	$3.4B
Total Non Current Assets	$26B
Property Plant Equipment	$7.3B
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$1.4B
Intangible Assets Excluding Goodwill	$1.4B
Goodwill	$15B
Investments	-
Long Term Investments	$1.4B
Short Term Investments	$163M
Other Current Assets	$1.1B
Other Non Current Assets	-
Total Liabilities	$18B
Total Current Liabilities	$5.7B
Current Accounts Payable	$984M
Deferred Revenue	-
Current Debt	-
Short Term Debt	$1.2B
Total Non Current Liabilities	$12B
Capital Lease Obligations	$4.1B
Long Term Debt	$6.3B
Current Long Term Debt	$577M
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$11B
Other Current Liabilities	$3.1B
Other Non Current Liabilities	$69M
Total Shareholder Equity	$15B
Treasury Stock	-
Retained Earnings	$11B
Common Stock	$293M
Common Stock Shares Outstanding	$587M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (EUR)
Operating Cashflow	$2.4B
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$1.7B
Capital Expenditures	$699M
Change In Receivables	-
Change In Inventory	$108M
Profit Loss	-
Cashflow From Investment	-$85M
Cashflow From Financing	-$2.6B
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$349M
Dividend Payout Common Stock	$349M
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$0
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$741M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (EUR)
Gross Profit	$4.8B
Total Revenue	$19B
Cost Of Revenue	$15B
Costof Goods And Services Sold	$15B
Operating Income	$1.4B
Selling General And Administrative	$2.4B
Research And Development	$183M
Operating Expenses	$3.4B
Investment Income Net	-
Net Interest Income	-$335M
Interest Income	$72M
Interest Expense	$407M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$1.7B
Income Before Tax	$1.1B
Income Tax Expense	$316M
Interest And Debt Expense	-
Net Income From Continuing Operations	$741M
Comprehensive Income Net Of Tax	-
Ebit	$1.5B
Ebitda	$3.2B
Net Income	$538M

Dividends

Field	Value
Ex Dividend Date	2025-05-23
Declaration Date	2025-05-07
Record Date	2025-05-23
Payment Date	2025-06-06
Amount	0.787104

FMS News

FMS Profile

Fresenius Medical Care Corporation Profile

Sector: HEALTHCARE

Industry: MEDICAL CARE FACILITIES

Fresenius Medical Care Corporation is a leading global provider of dialysis products and services, primarily catering to patients with chronic kidney disease. Headquartered in Bad Homburg, Germany, the company operates a vast network of dialysis clinics and offers a comprehensive range of renal care services in key markets including North America, Europe, and various international regions. With a commitment to improving patient outcomes and pioneering advancements in dialysis technology, Fresenius Medical Care plays a vital role in the healthcare sector, demonstrating resilience and potential for growth amid evolving industry dynamics.

Symbol	Price	Change %	Market Cap	Volume
VHAI	$0.00	-25.00%	$2.64M	500,101,768
YYAI	$0.16	-12.69%	$3.04M	348,018,306
STAI	$0.62	+39.44%	$29.16M	228,870,836
CGBS	$0.03	-39.47%	$18.16M	197,485,133
BURU	$0.50	+6.25%	$61.07M	194,081,267

Symbol	Price	Change %	Market Cap	Volume
AZN	$84.53	-0.59%	$266.24B	14,476,330
NVO	$57.76	+1.46%	$262.70B	6,534,796
UL	$60.43	+2.54%	$144.72B	5,310,821
PFE	$24.70	-0.30%	$143.50B	44,581,535
BSX	$95.41	-1.92%	$143.29B	8,055,978

Symbol	Price	Change %	Market Cap	Volume
JYD	$5.52	+4041.03%	$18.60M	120,845
LGCL	$3.91	+3994.24%	$12.95M	111,536
LPSN	$5.85	+1340.13%	$65.31M	447,889
PSIG	$4.50	+882.53%	$11.43M	278,434
CDT	$4.05	+727.89%	$2.34M	194,636

Symbol	Price	Change %	Market Cap	Volume
XELA	$0.00	-99.13%	$7.38M	12,512
GOTU	$3.01	-87.15%	$781.87M	389,578
TVRD	$6.57	-84.20%	$242.26M	5,876,844
SHOT	$0.39	-74.37%	$67.15M	13,958,900
PKBO	$0.02	-67.85%	$531.87K	66,140

Quick Links

FMS $0.00 (0.00% ) Quote details